Month: January 2026
Lerøy Seafood Group ASA has the pleasure of inviting investors, analysts and other stakeholders to its Capital Markets Days on March 2nd and 3rd, 2026.
Management Presentations
Management will present the Group’s strategic priorities, targets towards 2030, operational developments and capital allocation priorities at the Lerøy’s headquarters in Bergen, Norway, on March 2nd.
A live webcast will be available at www.leroyseafood.com/capitalmarketsday The webcast will include a Q&A session with the possibility of submitting questions digitally.
All presentations will be held in English.
A Tour of the Salmon and Trout Value Chain
Participants are invited to join a guided tour of Lerøy’s salmon and trout operations at Lerøy Sjøtroll in Austevoll on March 3rd.
Request for Participation
The management presentations on March 2nd will commence...
Pierrick Lefranc appointed as Executive Vice President Technical Operations, member of Executive Leadership Team
Written by Customer Service on . Posted in Public Companies.
Pierrick Lefranc EVP Technical OperationsPierrick Lefranc appointed as Executive Vice President (EVP) and member of the Executive Leadership Team (ELT), as of 1 April 2026PARIS, FRANCE, 27 January 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that Pierrick Lefranc will be appointed as Executive Vice President (EVP) and member of the Executive Leadership Team (ELT), as of 1 April 2026. Pierrick will succeed Aidan Murphy, EVP Technical Operations and Member of the ELT, who after 30 years of excellent service at Ipsen, will retire in March 2026.
Pierrick brings over 30 years of experience in the pharmaceutical industry. Throughout his career, he has led manufacturing operations and large-scale industrial projects, consistently driving improvements in productivity, quality, and regulatory compliance. Since July 2019,...
IBA signs contract for a Proteus®ONE proton therapy system to be located at the MacKay Memorial Hospital in New Taipei City, Taiwan
Written by Customer Service on . Posted in Public Companies.
Louvain-La-Neuve, Belgium, January 27, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the supply of a Proteus®ONE1 compact proton therapy solution to be installed at the MacKay Memorial Hospital in New Taipei City, Taiwan. This is the fourth order of a Proteus®ONE system in Taiwan, further reinforcing IBA’s position as the undisputed market leader.
The contract includes the delivery and the installation of a Proteus®ONE system as well as a comprehensive Quality Assurance package from IBA Dosimetry. As the market-leading compact proton therapy system, Proteus®ONE is designed to evolve and incorporate the latest technological advancements, ensuring...
Launch of the second phase of the Õielehe apartments development project (Rae parish, Estonia)
Written by Customer Service on . Posted in Public Companies.
Õielehe apartment buildingÕielehe apartment building visualizationÕielehe terraced houseÕielehe terraced house visualizationOÜ Merko Kodud, part of the AS Merko Ehitus group, has decided to launch the second phase of the Õielehe development project in Rae parish in Jüri. As part of this, three apartment buildings with a total of 33 apartments will be completed in the spring of 2027 at the addresses Õie 6, Õie 8 and Õie 10. Sales of apartments will also begin in a five-apartment terraced house, which will be built at the address Õie 1.
The sizes of the apartments in the two-story A-energy class apartment buildings of Õielehe homes (merko.ee/oielehe) range from 50 to 102 square meters, and prices per square meter start at 3,275 euros. The sizes of the two-story A-energy class apartments in the terraced house range from...
[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for its dual GLP-1/GIP receptor agonist CT-388 in people living with obesity
Written by Customer Service on . Posted in Public Companies.
A once-weekly subcutaneous injection of CT-388 achieved a statistically significant placebo-adjusted weight loss of 22.5% (p < 0.001) at 48 weeks at the highest dose tested (24 mg), without reaching a weight loss plateau
54% of participants on the 24 mg dose achieved resolution of obesity (BMI
Mountain Lake Acquisition Corp. II Announces the Upsized Pricing of $313.2 Million Initial Public Offering
Written by Customer Service on . Posted in Public Companies.
Incline Village, NV, Jan. 26, 2026 (GLOBE NEWSWIRE) — Mountain Lake Acquisition Corp. II (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company and led by Chief Executive Officer Paul Grinberg and Chief Financial Officer, Douglas Horlick, today announced the pricing of its upsized initial public offering of 31,320,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are expected to trade on the Global Market tier of the Nasdaq Stock Market (“Nasdaq”) under the ticker symbol “MLAAU” beginning January 27, 2026. No fractional warrants will be issued upon separation...
Fangzhou Issues Positive Profit Forecast as AI-Driven Chronic Care Model Delivers First Full-Year Profit
Written by Customer Service on . Posted in Public Companies.
SHANGHAI, Jan. 27, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, issued a positive profit forecast for 2025, citing stronger-than-expected revenue growth and its first year of full profitability, underscoring the commercial viability of its “AI + chronic care services” model.
In a filing released on January 25, the company said it expects full-year revenue for 2025 to reach between RMB 3.5 billion and RMB 3.55 billion, representing year-on-year growth of approximately 30%. Fangzhou also forecast a net profit of RMB 7 million to RMB 10 million, marking a transition to comprehensive profitability after achieving adjusted profitability in 2024.
The company attributed the revenue increase primarily to the continued expansion of its chronic...
Fangzhou Raises HK$150 Million in Share Placement to Accelerate AI-Powered Chronic Care Platform
Written by Customer Service on . Posted in Public Companies.
HONG KONG, Jan. 27, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, has successfully completed a HK$150 million share placement, strengthening its balance sheet to accelerate investment in artificial intelligence and platform upgrades.
The shares were priced at HK$3.32 per share, with the shares placed representing approximately 3.26% of the Company’s enlarged issued share capital following completion of the subscription.
Fangzhou plans to allocate approximately 90% of the net proceeds after deducting related costs and expenses to accelerate development of the Company’s AI-driven chronic disease management platform. This encompasses model development and optimization, infrastructure and computational resource expansion, talent...
Twin Hospitality Group Files Voluntary Chapter 11 Petitions to Strengthen Capital Structure
Written by Customer Service on . Posted in Public Companies.
DALLAS, Jan. 26, 2026 (GLOBE NEWSWIRE) — Twin Hospitality Group Inc. (Nasdaq: TWNP), the parent company of Twin Peaks Restaurant, today announced it has commenced voluntary chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District of Texas. Twin Hospitality plans to use the filings to deleverage the balance sheet, maximize value for its stakeholders, and support the continued growth of its brands.
Twin Hospitality develops and operates the specialty casual dining restaurant concepts, Twin Peaks and Smokey Bones. Throughout the chapter 11 process, Twin Hospitality expects the brands will remain open and operating as usual and will continue delivering their signature guest experiences. Trading of Twin Hospitality Group’s securities on NASDAQ is expected to continue with a “Q” suffix during this period.
“Twin...
Micron Breaks Ground on Advanced Wafer Fabrication Facility in Singapore
Written by Customer Service on . Posted in Public Companies.
Approximately $24 billion investment over 10 years will support long-term manufacturing requirements and AI-driven demand
SINGAPORE, Jan. 27, 2026 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) broke ground today on an advanced wafer fabrication facility located within the company’s existing NAND manufacturing complex in Singapore. This new facility represents a planned investment of approximately US $24 billion (SG $31 billion) over 10 years and is designed to ultimately provide 700,000 square feet of cleanroom space. Wafer output is scheduled to begin in the second half of calendar 2028, helping Micron address growing market demand for NAND technology driven by the rapid expansion of AI and data-centric applications.
The groundbreaking ceremony for this facility, Singapore’s first double-story wafer manufacturing...
